Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Clinical outcomes of patients with heart failure and preserved ejection fraction in Chinese

View through CrossRef
Background Although heart failure is recognised as a major health problem, little is known about heart failure with preserved ejection fraction (HFPEF) in the Chinese population. Therefore, we observed the clinical characteristics and outcomes of patients with HFPEF in China. Methods All patients admitted with heart failure were divided into the HFPEF (EF 3 50%) and reduced ejection fraction (HFREF, EF<50%) groups. EF was determined by echocardiography, and clinical data were collected from a secure web-based system. Results Out of the 534 patients with heart failure, 269 (50.4%) had HFPEF. Compared to patients with HFREF, patients with HFPEF were older, were more likely to be female and had a higher prevalence of hypertension. The in-hospital mortality of patients with HFPEF (3.7%) was comparable to that of patients with HFREF (4.5%). After a mean follow-up period of 321 days, the survival of patients with HFPEF (12.7%) was significantly better than that of patients with HFREF (23.3%, p=0.02). Cox proportional hazard regression identified serum creatinine levels (HR 1.006, 95% CI 1.001 to 1.009, p=0.009) and hypertension (HR 2.104, 95% CI 1.016 to 4.359, p=0.045) as predictors of survival for patients with HFPEF. Conclusions HFPEF is common in China. Although the in-hospital mortality of patients with HFPEF was comparable to that of patients with HFREF, the survival of patients with HFPEF was significantly better than that of patients with HFREF during a follow-up period lasting more than half a year after discharge.
Title: Clinical outcomes of patients with heart failure and preserved ejection fraction in Chinese
Description:
Background Although heart failure is recognised as a major health problem, little is known about heart failure with preserved ejection fraction (HFPEF) in the Chinese population.
Therefore, we observed the clinical characteristics and outcomes of patients with HFPEF in China.
Methods All patients admitted with heart failure were divided into the HFPEF (EF 3 50%) and reduced ejection fraction (HFREF, EF<50%) groups.
EF was determined by echocardiography, and clinical data were collected from a secure web-based system.
Results Out of the 534 patients with heart failure, 269 (50.
4%) had HFPEF.
Compared to patients with HFREF, patients with HFPEF were older, were more likely to be female and had a higher prevalence of hypertension.
The in-hospital mortality of patients with HFPEF (3.
7%) was comparable to that of patients with HFREF (4.
5%).
After a mean follow-up period of 321 days, the survival of patients with HFPEF (12.
7%) was significantly better than that of patients with HFREF (23.
3%, p=0.
02).
Cox proportional hazard regression identified serum creatinine levels (HR 1.
006, 95% CI 1.
001 to 1.
009, p=0.
009) and hypertension (HR 2.
104, 95% CI 1.
016 to 4.
359, p=0.
045) as predictors of survival for patients with HFPEF.
Conclusions HFPEF is common in China.
Although the in-hospital mortality of patients with HFPEF was comparable to that of patients with HFREF, the survival of patients with HFPEF was significantly better than that of patients with HFREF during a follow-up period lasting more than half a year after discharge.

Related Results

Empagliflozin in the Real World: Strengthening Heart Failure Care in Pakistan
Empagliflozin in the Real World: Strengthening Heart Failure Care in Pakistan
Heart failure with reduced ejection fraction (HFrEF) remains a major clinical challenge worldwide and is a pressing public health issue in Pakistan. Patients here often present at ...
Comorbidities and sex differences in chronic heart failure of ischemic etiology
Comorbidities and sex differences in chronic heart failure of ischemic etiology
Abstract Background: Comorbidities and sex differences play a major role in chronic heart failure (CHF). However, it is unknown whether the prevalence of comorbidities diff...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
PATOMEKANISME PENYAKIT GAGAL JANTUNG KONGESTIF
PATOMEKANISME PENYAKIT GAGAL JANTUNG KONGESTIF
Heart failure is a clinical syndrome characterized by abnormalities in the structure or function of the heart, resulting in inability of heart to pump blood to meet the metabolic n...

Back to Top